Breast Conservation Surgery as Effective as Mastectomy for Some Large Breast Tumors
Findings suggest doctors shouldn’t automatically rule out less invasive surgery plus radiation for some larger breast tumors.
Tumors
Model shows how cancerous tumors manipulate blood-vessel growth
A detailed simulation has made a more detailed examination of how tumors manipulate blood-vessel growth to their advantage.
Response to new drug in patients with lymphomas and advanced solid tumors
Patients with B-cell non-Hodgkin lymphomas and advanced solid tumors have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial.
Antimalarial inhibits tumor growth and metastases
A recent study has demonstrated that the malaria drug chloroquine normalizes the abnormal blood vessels in tumors, which can aid in blocking cancer cell dissemination and metastasis.
New nanoparticle could improve MRI scanning for cancer diagnosis
A research team has created a new, self-assembling nanoparticle that can increase the effectiveness of magnetic resonance imaging (MRI) cancer detection.
Common clinical practice described for incompletely resected lung cancer
A landmark survey of more than 700 specialists provides crucial real-world insight into the treatments that most oncologists choose for lung cancer patients whose tumor has been incompletely resected.
New type of cancer has been discovered
An abnormal yet recurring chromosomal mismatch causes a little-known facial tumour that is more common in women.
Tumor size is strongest variable in patient response to promising melanoma drug
In examining why some advanced melanoma patients respond so well to the experimental immunotherapy MK-3475, while others have a less robust response, researchers at Mayo Clinic in Florida found that the size of tumors before treatment was the strongest variable.
Metastatic tumor sites predict OS in castration resistant prostate cancer
The site of metastatic tumors powerfully predicts overall survival (OS) among men with metastatic castration resistant prostate cancer (mCRPC), confirms a meta-analysis presented at the 2014 American Society of Clinical Oncology Annual Meeting.
‘Excellent’ survival in biology-based pediatric neuroblastoma treatment reduction
Tumor biology-based therapy offers excellent outcomes among children with intermediate risk neuroblastoma, according to results from a prospective phase 3 reduction of therapy study.
- Loading...
Loading...
Next post in ASCO 2014 Annual Meeting
Loading... 
Loading...